These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9934543)

  • 41. Update on the use of cefotaxime for pediatric meningitis in Portugal.
    Lecour H; Miranda AM; Nogueira JA; Abreu C
    Diagn Microbiol Infect Dis; 1995; 22(1-2):125-7. PubMed ID: 7587025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cefotaxime in the treatment of lower respiratory tract infections.
    Beumer HM; Veldkamp J; Deleers L
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):605-10. PubMed ID: 6321367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of a low dose of cefotaxime in serious chest infections.
    Cade JF; Presneill J; Keighley C; Sinickas V
    Chest; 1992 May; 101(5):1393-8. PubMed ID: 1582303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field. Pediatric Study Group of ME1207].
    Fujii R; Yoshioka H; Okuno A; Fujita K; Murono K; Maruyama S; Sakata H; Iseki K; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1993 Jan; 46(1):95-114. PubMed ID: 8455336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cefotaxime use in pediatric infections.
    Dajani AS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):105-10. PubMed ID: 7587022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical studies on cefotiam in pediatric infections (author's transl)].
    Okamoto K; Shino K; Fuke H; Watanabe K; Ozaki H
    Jpn J Antibiot; 1981 Jun; 34(6):1019-26. PubMed ID: 6270418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.
    Abbate GF; Alagia I; Giaquinto E; Leonessa V; Savioli L; Altucci P; Caputi M; Guarino C; Micillo E; Catena E
    Respiration; 1986; 49(3):222-30. PubMed ID: 3515468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized clinical trial of ceftizoxime and cefamandole in the treatment of serious lower respiratory tract infections.
    Rodriguez J; Vazquez GJ; Bermudez RH; Luina A; Ronda CH
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():209-13. PubMed ID: 6296008
    [No Abstract]   [Full Text] [Related]  

  • 49. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia. Results of a multicenter study.
    Shah PM; Stille W
    Diagn Microbiol Infect Dis; 1995; 22(1-2):171-2. PubMed ID: 7587035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Laboratory and clinical studies of cefodizime in pediatric field].
    Nakao Y; Takeuchi H; Kimura H; Ishikawa H; Hayakawa F; Kuno K
    Jpn J Antibiot; 1989 Jun; 42(6):1336-45. PubMed ID: 2795857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cefotaxime (klaforan) in modern therapy of bacterial infections].
    Khess R; Budanov SV
    Antibiot Khimioter; 1996 Mar; 41(3):44-56. PubMed ID: 8967803
    [No Abstract]   [Full Text] [Related]  

  • 53. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical studies of cefodizime in the pediatric field].
    Niino M; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1989 Jun; 42(6):1400-13. PubMed ID: 2795864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical studies on cefmenoxime in pediatric field].
    Yanagisawa K; Yanagisawa K; Hoshina H; Ichihashi H
    Jpn J Antibiot; 1982 Oct; 35(10):2414-22. PubMed ID: 6306293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children.
    Scholz H; Hofmann T; Noack R; Edwards DJ; Stoeckel K
    Chemotherapy; 1998; 44(2):142-7. PubMed ID: 9551246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacodynamic (kinetic) considerations in the treatment of moderately severe infections with cefotaxime.
    Turnidge JD
    Diagn Microbiol Infect Dis; 1995; 22(1-2):57-69. PubMed ID: 7587052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of lower respiratory tract infections including pneumonia. Comparative study with i.vl cefotaxime/oral cefixime versus parenteral cefotaxime].
    Vogel F
    Fortschr Med; 1994 Oct; 112(28):395-8. PubMed ID: 7988978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical investigation of cefdinir in the pediatric field].
    Takekuma K; Tsuyuki K; Honda T
    Jpn J Antibiot; 1990 Oct; 43(10):1806-12. PubMed ID: 2086818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.